Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that on September 30, 2024 it granted stock options to purchase an ...

We look forward to presenting our latest intercom solutions at NAB NY 2024,” said Gary Rosen, Vice President of Global Sales ...

Pliant Technologies, a leading provider of professional wireless intercom solutions, has announced that it will be showing a ...

The National Democratic Congress (NDC) has criticised the Ghana Police Service for allowing itself to be controlled and used ...

SOUTH SAN FRANCISCO, CA - Pliant Therapeutics, Inc. (NASDAQ:PLRX), a biopharmaceutical company, announced on Monday an update to its corporate bylaws to reflect recent changes in Delaware law.

Pliant Therapeutics Inc (PLRX) stock saw a modest uptick, ending the day at $11.33 which represents a slight increase of $0.01 or 0.09% from the prior close of $11.32. The stock opened at $11.37 and ...

Trump has campaigned on a wave of retaliatory criminal prosecutions. It’s not the first time he’s promised to lock up his ...

SOUTH SAN FRANCISCO, CA - Pliant Therapeutics, Inc. (NASDAQ:PLRX), a biopharmaceutical company, announced on Monday an update to its corporate bylaws to reflect recent changes in Delaware law. The ...

Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Pliant Therapeutics (PLRX – Research Report) today and set a price target ...

Leerink Partners analyst Faisal Khurshid has maintained their bullish stance on PLRX stock, giving a Buy rating on September 13. Faisal ...

Piper Sandler has reaffirmed its Overweight rating on shares of Pliant Therapeutics (NASDAQ: PLRX), maintaining a $40.00 price target. The endorsement follows a recent announcement from Boehringer ...